Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations.
Lin JJ, Horan JC, Tangpeerachaikul A, Swalduz A, Valdivia A, Johnson ML, Besse B, Camidge DR, Fujino T, Yoda S, Nguyen-Phuong L, Mizuta H, Bigot L, Nobre C, Lee JB, Yu MR, Mente S, Sun Y, Kohl NE, Porter JR, Shair MD, Zhu VW, Felip E, Cho BC, Friboulet L, Hata AN, Pelish HE, Drilon A. Lin JJ, et al. Among authors: swalduz a. Cancer Discov. 2024 Dec 2;14(12):2367-2386. doi: 10.1158/2159-8290.CD-24-0231. Cancer Discov. 2024. PMID: 39269178 Free PMC article. Clinical Trial.
Combined proteomic and transcriptomic approaches reveal externalized keratin 8 as a potential therapeutic target involved in invasiveness of head and neck cancers.
Albaret MA, Paré A, Malet L, De Souza G, Lavergne E, Goga D, De Pinieux G, Castellier C, Swalduz A, Robin V, Lavergne V, Mertani HC, Treilleux I, Vermot-Desroches C, Diaz JJ, Saintigny P. Albaret MA, et al. Among authors: swalduz a. Transl Oncol. 2021 Jan;14(1):100878. doi: 10.1016/j.tranon.2020.100878. Epub 2020 Sep 30. Transl Oncol. 2021. PMID: 33010552 Free PMC article.
Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer.
Doubre H, Greillier L, Justeau G, Ricordel C, Swalduz A, Curcio H, Bylicki O, Auliac JB, Guisier F, Bigay-Game L, Bernardi M, Pinsolle J, Amrane K, Decroisette C, Descourt R, Chouaid C, Geier M. Doubre H, et al. Among authors: swalduz a. J Cancer Res Clin Oncol. 2023 Nov;149(16):15095-15102. doi: 10.1007/s00432-023-05321-w. Epub 2023 Aug 25. J Cancer Res Clin Oncol. 2023. PMID: 37626173
[Enteral nutrition in malnourished patients with lung cancer].
Pierret T, Fontaine É, Pérol M, Avrillon V, Swalduz A, Pinsolle J, Giaj-Levra M, Moro-Sibilot D, Toffart A. Pierret T, et al. Among authors: swalduz a. Rev Mal Respir. 2020 Apr;37(4):349-351. doi: 10.1016/j.rmr.2020.02.012. Epub 2020 Apr 9. Rev Mal Respir. 2020. PMID: 32279889 French. No abstract available.
Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA study.
Lochmann M, Girodet M, Despax J, Baudry V, Duranti J, Mastroianni B, Vanacker H, Vinceneux A, Brahmi M, Renard O, Verlingue L, Amini-Adle M, Swalduz A, Gautier J, Ducimetière F, Anota A, Cassier PA, Chvetzoff G, Christophe V. Lochmann M, et al. Among authors: swalduz a. Support Care Cancer. 2024 May 15;32(6):353. doi: 10.1007/s00520-024-08535-x. Support Care Cancer. 2024. PMID: 38748187
Occupational asbestos exposure and survival among lung cancer patients.
Noelle H, Pérol O, Pérol M, Avrillon V, Belladame E, Fayette J, Fournié F, Swalduz A, Dessemon J, Blay JY, Neidhardt EM, Saintigny P, Tabutin M, Boussageon M, Praud D, Charbotel B, Fervers B. Noelle H, et al. Among authors: swalduz a. Lung Cancer. 2023 May;179:107182. doi: 10.1016/j.lungcan.2023.107182. Epub 2023 Mar 23. Lung Cancer. 2023. PMID: 37001440
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trial.
Bylicki O, Guisier F, Scherpereel A, Daniel C, Swalduz A, Grolleau E, Bernardi M, Hominal S, Prevost JB, Pamart G, Marques MH, Cloarec N, Deshayes S, Raimbourg J, Veillon R, Oulkhouir Y, Audigier Valette C, Subtil F, Chouaïd C, Greillier L; GFPC. Bylicki O, et al. Among authors: swalduz a. Lung Cancer. 2024 Aug;194:107866. doi: 10.1016/j.lungcan.2024.107866. Epub 2024 Jun 29. Lung Cancer. 2024. PMID: 38972083 Free article.
50 results